SignalRx launches Practice Intelligence for healthcare sellers

SignalRx has launched Practice Intelligence for enterprises that sell to healthcare practices, groups and MSOs. The New York company says the platform helps revenue teams find expansion, cut churn and target new customers as ownership in healthcare continues to consolidate.

Why it matters: - Healthcare buying decisions are shifting from individual practices to larger groups, MSOs, DSOs and private equity-backed platforms. - SignalRx is pitching Practice Intelligence as a way for commercial teams to sell at the level that actually controls purchasing, renewals and expansion. - The platform is aimed at helping enterprises uncover growth sooner, before competitors win the account or churn shows up at renewal.

What happened: - SignalRx on Oct. 29, 2026 launched Practice Intelligence for enterprises that sell to healthcare practices, groups and MSOs. - The platform combines a company’s own customer data with ongoing research into healthcare practices and the organizations that own them. - SignalRx said the product gives commercial teams a current view of customers, market coverage and growth opportunities. - The company will demo Practice Intelligence at HLTH USA 2026 in Las Vegas from Nov. 15-18 at booth 127-92 in the Startup Pavilion at the Venetian Expo. - More information is available on SignalRx's website.

The details: - Practice Intelligence connects CRM, billing and product usage data with external research on ownership and market changes. - The platform is organized around four commercial use cases: understanding ownership, growing existing customers, reducing churn and targeting new customers. - Ownership mapping ties each practice to the group, MSO, DSO or private equity platform behind it. - Expansion analysis identifies accounts that resemble a company’s best customers but buy less. - Churn signals combine usage and spend changes with external indicators such as provider and ownership shifts. - New-customer targeting ranks net-new practices and groups by similarity to a company’s highest-value accounts. - SignalRx said the platform delivers intelligence directly into Salesforce and other tools commercial teams already use. - The company said it manages both the integration and the ongoing intelligence layer, reducing the need for customers to build their own data infrastructure. - SignalRx said it has analyzed more than 100 million customer and market signals since launching last year.

Between the lines: - The launch reflects a broader problem in healthcare selling: many CRMs still track practices individually even after those practices have been rolled into larger ownership structures. - SignalRx is positioning data on ownership changes as a commercial trigger, not just a market-research feature. - The product also suggests a shift from static account lists to continuously updated segmentation that can influence territory planning, retention and upsell strategy. - Tom Zampini, SignalRx founder and CEO, said a practice in a CRM may now be one of dozens of locations owned by the same group, and that understanding ownership and change shows where to focus.

What's next: - SignalRx will use HLTH USA 2026 to show how Practice Intelligence works in practice for healthcare-focused sales and customer-success teams. - The company is likely to lean on the platform’s Salesforce integration and always-current data pitch as buyers look for less manual account management. - More consolidation in physician and dental markets could make ownership intelligence more important for future enterprise sales teams.

The bottom line: - SignalRx is betting that the next edge in healthcare sales is knowing who really owns the account, not just which practice is in the CRM.